您的位置: 首页 > 农业专利 > 详情页

a cell effettrice modified for the treatment of cancers expressing the disialonganglioside gd2
专利权人:
SPANO MARIA CARLOTTA;CALDRER SARA;DOMINICI MASSIMO;PAOLUCCI PAOLO
发明人:
BESTAGNO MARCO,CALDRER SARA,CAMPANA DARIO,DOMINICI MASSIMO,PAOLUCCI PAOLO,SPANO MARIA CARLOTTA
申请号:
ITMO20110270
公开号:
ITMO20110270A1
申请日:
2011.10.25
申请国别(地区):
IT
年份:
2013
代理人:
摘要:
A modified effector cell includes a non-reversibly produced vector-encoded anti-GD2-BB-ζ chimeric receptor for use in disialoganglioside GD2-expressing neoplasia, which is inserted in the cell, to obtain an effector cell that stably produces the anti-GD2-BB-ζ chimeric receptor, the chimeric receptor having two distinct mutually fused portions, i.e. an intra-cytoplasmic portion and an extra-cytoplasmic portion.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充